Table 5 Differences in prescribed drugs for women in different BMI-categories: bivariate and multilevel analyses

Alimentary tract and metabolism (A)

16.7

23.4

30.4

p < 0.001

1.13

[0.96–1.34]

1.53*

[1.24–1.90]

Blood and blood forming organs (B)

9.0

11.7

15.5

p < 0.001

0.90

[0.72–1.12]

1.16

[0.88–1.54]

Cardiovascular system (C)

15.1

28.8

37.8

p < 0.001

1.58*

[1.33–1.88]

2.53*

[2.02–3.16]

Dermatologicals (D)

23.4

24.5

32.4

p < 0.001

1.00

[0.85–1.16]

1.45*

[1.18–1.77]

Genito urinary system and sex homones (G)

37.9

28.7

26.5

p < 0.001

1.03

[0.88–1.21]

0.87

[0.70–1.09]

Systemic hormonal preparations (H)

5.4

8.4

10.7

p < 0.001

1.23

[0.95–1.58]

1.53*

[1.12–2.11]

Antiinfectives for systemic use (J)

28.9

36.9

42.1

p < 0.001

1.11

[0.96–1.28]

1.35*

[1.12–1.64]

Antineoplastic and immunomodulating agents (L)

0.8

0.9

1.5

ns

0.97

[0.48–1.97]

1.61

[0.72–3.60]

Musculoskeletal system (M)

20.6

29.6

36.0

p < 0.001

1.38*

[1.18–1.60]

1.75*

[1.43–2.14]

Nervous system (N)

26.1

33.1

35.0

p < 0.001

1.09

[0.94–1.26]

1.15

[0.94–1.40]

Antiparasitic products (P)

1.5

0.9

1.5

ns

0.72

[0.39–1.35]

0.94

[0.41–2.16]

Respiratory system (R)

20.9

25.1

31.1

p < 0.001

1.23*

[1.05–1.44]

1.62*

[1.33–1.99]

Sensory organs (S)

9.7

11.6

11.8

ns

1.04

[0.85–1.29]

1.03

[0.78–1.38]